|
|
|
Volumn 2, Issue 1, 2000, Pages 21-25
|
|
Towards genomic cancer pharmacology: Innovative drugs for the new millenium
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE;
ACYLTRANSFERASE;
ANGIOGENESIS INHIBITOR;
ANTIESTROGEN;
ANTINEOPLASTIC AGENT;
CYCLIN DEPENDENT KINASE;
FLAVOPIRIDOL;
GEFITINIB;
HISTONE DEACETYLASE;
IMATINIB;
INTEGRIN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PIFITHRIN ALPHA;
PROTEIN KINASE;
PROTEIN P53;
PROTEIN TYROSINE KINASE;
PROTEIN TYROSINE KINASE INHIBITOR;
PROTEINASE;
RAF PROTEIN;
TELOMERASE;
TRANSFERASE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
APOPTOSIS;
BREAST CANCER;
CANCER;
CANCER CELL;
CARCINOGENESIS;
CELL PROLIFERATION;
CHRONIC MYELOID LEUKEMIA;
DRUG TARGETING;
EDITORIAL;
GENE TARGETING;
GENE THERAPY;
HUMAN;
MEDICAL TECHNOLOGY;
MOLECULAR GENETICS;
SOLID TUMOR;
|
|
EID: 0034087224
PISSN: 14648466
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (11)
|
|
References (14)
|
